Abstract:Background: Reduced olfaction is a common feature of patients with typical Parkinson disease (PD). We sought to develop and validate a simplified smell test as a screening tool to help identify PD patients and explore its differentiation from other forms of parkinsonism. Methods: We used the Sniffin' Sticks Identification Test (SST-ID) and the University of Pennsylvania Smell Identification Test (UPSIT), together with data from three case-control studies, to compare olfaction in 301 patients with PD or dementia with Lewy bodies (DLB) to 36 subjects with multiple system atrophy (MSA), 32 individuals with progressive supranuclear palsy (PSP) and 281 neurologically healthy controls. Individual SST-ID and UPSIT scents were ranked by area under the receiver operating characteristic curve (AUC) values for group classification, with 10-fold cross-validation. Additional rankings were generated by leveraging results from eight published studies, collectively including 5,853 unique participants. Lead combinations were further validated using (semi-)independent datasets. An abbreviated list of scents was generated based on those shared by SST-ID and UPSIT. Findings: We made the following five observations: (i) PD and DLB patients generally had worse olfaction than healthy controls, as published, with scores for MSA and PSP patients ranking as intermediate. (ii) SST-ID and UPSIT scents showed distinct discriminative performances, with the top odorants (licorice, banana, clove, rose, mint, pineapple and cinnamon) confirmed by external evidence. (iii) A subset of only seven scents demonstrated a similar performance to that of the complete 16-scent SST-ID and 40-scent UPSIT kits, in both discovery and validation steps. Seven scents distinguished PD/DLB subjects from healthy controls with an AUC of 0.87 (95%CI 0.85-0.9) and PD/DLB from PSP/MSA patients with an AUC of 0.73 (95%CI 0.65-0.8) within the three cohorts (n=650). (iv) Increased age was associated with a decline in olfaction. (v) Males generally scored lower than females, although this finding was not significant across all cohorts. Interpretation: Screening of subjects for typical Parkinson's-associated hyposmia can be carried out with a simplified scent identification test that relies on as few as seven specific odorants. There, the discrimination of PD/DLB subjects vs. age-matched controls is more accurate than that of PD/DLB vs. PSP/MSA patients. Funding: This work was supported by: Parkinson Research Consortium; uOttawa Brain & Mind Research Institute; and the Aligning Science Across Parkinson's Collaborative Research Network.

Diagnostic value of vietnamese smell identification test in Parkinson's disease

Comparing smell identification ability among different motor subtypes of Parkinson's disease using the Vietnamese Smell Identification Test and the Brief Smell Identification Test

Development and validation of the Vietnamese smell identification test

A Fast and Non-Invasive Artificial Intelligence Olfactory-Like System That Aids Diagnosis of Parkinson's Disease

Sensitivity of Sniffer Dogs for a Diagnosis of Parkinson's Disease: A Diagnostic Accuracy Study.

Application of Odor Identification Test in Parkinson's Disease in China: A Matched Case-Control Study

Sniffin’ Sticks test in evaluating olfactory function in Parkinson’ s disease

Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson's disease

Odor Selectivity of Hyposmia and Cognitive Impairment in Patients with Parkinson's Disease.

China's Modified Version of Sniffin' Sticks 12‐Identification Test Used in Chinese Parkinson's Disease and Multiple System Patients: Comparison of Three Olfactory Testing Methods

Odor Identification Test in Idiopathic REM-Behavior Disorder and Parkinson's Disease in China

Development of a Simplified Smell Test to Identify Patients with Typical Parkinson's as Informed by Multiple Cohorts, Machine Learning and External Validation

Comparison of Olfactory Identification Patterns among Parkinson's Disease Patients from Different Countries

The Discriminative Power of Different Olfactory Domains in Parkinson's Disease

The Predictive Value of SS-16 in Clinically Diagnosed Parkinson’s Disease Patients: Comparison with 99m Tc-TRODAT-1 SPECT Scans

SPECT Molecular Imaging in Parkinson's Disease

Artificial Intelligent Olfactory System for the Diagnosis of Parkinson’s Disease

Olfactory Dysfunction and Its Relationship with Clinical Features of Parkinson's Disease

Olfaction and cognitive performance in early‐stage Parkinson’s disease

Performance of a cost-effective olfactory test to evaluate hyposmia in Parkinson's disease patients

Comparison of Vagus Nerve Cross-Sectional Area Between Brain-First and Body-First Parkinson’s Disease